Immunotherapy boosts the immune system to fight cancer but may cause skin side effects; early reporting helps manage symptoms ...

Mr. Kim, 62 years old, a man preparing for retirement, was an office worker diligently attending to his job just a year ago.

Experts at Cincinnati Children's report proof-of-concept results that may sharply reduce the risk of a lethal side effect that has negatively impacted the use of revolutionary cancer immunotherapies ...

The cancer drugs called PARP inhibitors have a puzzling reputation: even though they are treatment mainstays for multiple forms of cancer, they can damage cancer-killing T cells and disrupt the ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...

In a meta-analysis of solid organ transplant recipients with advanced cancer taking immune checkpoint inhibitors, half of patients died and 1 in 5 experienced graft loss. In solid organ transplant ...

A new editorial was published in Volume 12 of Oncoscience on May 2, 2025, titled "Immune checkpoint inhibitors and myocarditis: Lessons from a nationwide cohort study." In this editorial, Bishal ...

In the past decade, immune checkpoint inhibitors (ICIs) have dramatically changed cancer treatment, significantly improving ...